Complete DiGeorge Syndrome: Clinical Trials

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2
Phase 1	1	Completed 1

Follow Complete DiGeorge Syndrome: new trials by email Literature Review of Complete DiGeorge Syndrome trials Research Report on Complete DiGeorge Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Phase I/II Thymus Transplantation With Immunosuppression #950 Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly	Phase 1 / Phase 2	Completed	Sumitomo Pharma Switzerland GmbH	14	2005-12-19	2022-03-25
Thymus Transplantation Dose in DiGeorge #932 Cultured Thymus Tissue Implantation (CTTI), Cultured Thymus Tissue Implantation with Parathyroid Transplantation - DiGeorge Anomaly, DiGeorge Syndrome	Phase 2	Completed	Sumitomo Pharma Switzerland GmbH	7	2004-09-02	2022-03-25

Narrower conditions

DiGeorge Syndrome (2)  ·  Hypocalcemia (2)  ·  Hypoparathyroidism (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Thymic aplasia (2)

Broader conditions

22q11 Deletion Syndrome (2)  ·  Abnormalities, Multiple (2)  ·  Calcium Metabolism Disorders (2)  ·  Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Chromosome Disorders (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Craniofacial Abnormalities (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)

Interventions

Thymus Extracts (2)  ·  Antilymphocyte Serum (1)  ·  Blood Specimen Collection (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Daclizumab (1)  ·  Drug Implants (1)  ·  Methylprednisolone (1)  ·  Mycophenolic Acid (1)  ·  Phlebotomy (1)  ·  Prednisolone (1)  ·  Steroids (1)  ·  Tacrolimus (1)  ·  Transplantation (1)  ·  thymoglobulin (1)

Sponsors

Sumitomo Pharma Switzerland GmbH (2)

Countries

United States (2)

Top investigators

M. Louise Markert, MD, PhD (2)

Results publications

PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 17284531, PMID 21565561, PMID 23607606, PMID 23914737

NIH funding

K12HD043494 (2), R01AI047040 (2), R01AI054843 (2), R56AI047040 (1)